Surrozen Inc SRZN
$22.21
▲ +6.63%
(+$1.38)
⬆️ Above Yest. High
🔥 High Short Interest
🎈 Low Float
🗓️ Earnings Next Week
Open
$21.00
Prev Close
$20.83
Day Range
$20.75 – $22.58
52W Range
$9.03 – $35.00
Market Cap
$257.87M
Beta
0.56
EPS (TTM)
$-35.44
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-11-23 |
| Shares Out. | 11,610,000 |
| Website | surrozen.com ↗ |
| Phone | 13026587581 |
| Employees | 44 |
| Revenue | $5.0M |
| Gross Profit | $5.0M |
| Net Income | -$127.5M |
| Free Cash Flow | -$33.7M |
| Total Assets | $120.7M |
| Total Liabilities | $398.9M |
| Equity | -$278.1M |
About Surrozen Inc
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Surrozen Inc is a publicly traded company under the ticker symbol SRZN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)